Flavay’s® action is synergistic for athletes: it protects the body by helping neutralize the naturally occurring
pro-oxidative effects of strenuous workouts, and strengthens the body’s collagen, which is a major component of muscles, tendons, cartilage, ligaments and bones.
Flavay® can help
minimize damage and accelerate recovery time from strenuous workouts,
sports-related activities and postoperative inflammation.
Flavay® has been licensed and sold in France for treating inflammation
and edema (swelling) since 1950 and is now available
in the United States as a dietary supplement. Research shows several ways
that Flavay® can help minimize damage and accelerate recovery time
from strenuous workouts and sports-related activities.
Flavay’s® action is synergistic for athletes: it protects
the body by helping neutralize the naturally occurring pro-oxidative effects
of strenuous workouts, and strengthens the body’s collagen, which
is a major component of muscles, tendons, cartilage, ligaments and bones.
Flavay’s® ability to strengthen and rebuild collagen is important
to injury-recovery because most athletic injuries involve damaged capillaries
(tiny blood vessels), caused by torn muscles, sprains, fractures or twisting
and whiplash. Strengthening of the vascular walls in the capillaries prevents
fluids from seeping and swelling in the connective tissues. These types
of injuries are painful and usually cause other problems, such as a loss
in physical condition when the injury causes an inability to train or
compete.
In an Australian study conducted
on injured soccer players, those that consumed Flavay® experienced
significantly less swelling than those who did not.
Research has shown that Flavay’s® ability to strengthen vascular
walls may help the body to repair injuries faster. In an Australian study
conducted on two groups of soccer players that had sustained injuries,
those that consumed Flavay® for ten days following their injuries
experienced significantly less swelling than those who did not and, in
some of those taking Flavay®, the swelling had completely disappeared.
Other research has demonstrated the ways in which Flavay® may actually
inhibit inflammation including double-blind studies conducted in France
which showed that Flavay® can also reduce postoperative inflammation.
Flavay® is a Natural, Non-Drug Anti-Inflammatory
Inflammation is caused by the overproduction of free radicals in a specific
area of the body. We now know that antioxidants work together to defeat
free radicals and inhibit the biological pathway that triggers inflammation,
and Flavay® is particularly effective as an anti-inflammatory.
Flavay® selectively binds to the connective tissue of joints, preventing inflammation
and lessening pain.
Flavay® can selectively bind to the connective tissue of joints,
preventing inflammation and lessening pain. One of the very first benefits
observed and studied Dr. Jack Masquelier, in as early as 1947, was the
anti-inflammatory effect of Flavay®.
Research demonstrates that Flavay® inhibits the release and synthesis
of histamine (which produces accelerated blood flow, dilates capillaries
and increases their permeability, thereby leaking plasma into surrounding
tissue), a key factor in the promotion of inflammation.
Studies demonstrate that the anti-histamine action of Flavay®
is obtained through inhibiting the activity of the enzyme histidine decarboxylase.
Dr. Masquelier’s research has been confirmed by German studies which
show that Flavay® may lower the production of histamine with as
much as 86% inhibition of histidine decarboxylase.
Flavay® also neutralizes free radicals that promote swelling and
cause inflammation. A free radical called superoxide is involved in the
inflammation of arthritis and several experiments show that Flavay®
quenches the superoxide free radicals.
Edema (Swelling)
Edema is an uncomfortable condition and can be both painful and dangerous.
Swollen and painful legs and ankles, puffiness of the eyes and an overall
bloated look and feel are examples of edema. It involves the leakage of
blood serum into surrounding tissues and Flavay® has shown that
it can reduce this leakage by strengthening capillary walls.
All of those taking
Flavay® for edema (swelling) had relief from at least some
of the symptoms.
Italian scientists from the University of Florence studied the effect
of Flavay® on venous congestion (edema) in the legs. The study involved
40 subjects consisting of 13 men and 27 women between the ages of 34 and
74. The subjects were randomly divided into two groups. One group received
a placebo and the other group received 300 mg of Flavay® daily for
60 days.
All of those taking the Flavay® had relief from at least some of
the symptoms. After 30 days, the pain was totally relieved in in 38 percent
of those taking Flavay®, the swelling disappeared in 26 percent
(the circumference of the legs was measured above the ankle), and 11 percent
experienced a decrease in the feeling of heaviness in their lower limbs.
After 60 days, the pain was totally relieved in 67 percent of those taking
Flavay®, the swelling disappeared in 63 percent, and the decrease
in heaviness jumped to 33 percent.
“Radical Scavenger” Effect of Flavay®
Flavay® is the product—used in the actual experiments—by
which Dr. Jack Masquelier established the "Radical
Scavenger Effect."
Flavay’s® strong antioxidant power acts as a scavenger
of the free radicals that play a major role in the initiation, duration
and breakdown of inflammation and the degradation of collagen.
"[A] method for preventing and fighting the harmful biological
effects of free radicals in the organism of warm blooded
animals and more especially human beings, namely cerebral involution,
hypoxia following atherosclerosis, cardiac or cerebral infarction,
tumour promotion, inflammation, ischaemia, alterations
of the synovial liquid, collagen degradation, among
others. The method consists in administering to said animals and
especially to human beings an amount, efficient against said effects,
of a plant extract with a proanthocyanidins content which has a
radical scavenger effect"—Dr. Jack Masquelier,
1987.
During any challenge to your immune system—because of disease, infections,
toxic exposure, stress or aging—you need the extra antioxidant power
in Flavay®
to help scavenge the free radicals naturally produced by the
immune system's cells during warfare. When your immune system works better,
your joints hurt less and your blood flows better.
This means that your immune system works better so that your joints hurt
less and your blood flows better—all because of Flavay®.
Sports and Exercise Increase the Body's Need
for Antioxidants
Exercise increases your body's
need for antioxidants.
Exercise is extremely beneficial, but many do not realize that exercise
increases the body's need for antioxidants. The fuel our bodies require
for sports and exercise is oxygen. Yet the body's production of energy
from oxygen can also wreak havoc in the body because it produces free
radicals. If we are deficient in antioxidants, the benefits of exercise
are diminished by the damage caused by free radicals. Thus, the key to
good health, is to maintain the right balance between antioxidants
and free radicals. It's not surprising, therefore, that studies have suggested
that antioxidants like Flavay® can actually improve athletic
performance and endurance.
Superior Antioxidant Support
Flavay® is superior to other antioxidants because its protective
effects are multiplied in the body. While it provides its own, powerful
antioxidant protection, it also supports the dynamic interplay between
other antioxidants in the body. Flavay’s® ability to “recycle,”
or regenerate vitamins C and E after they have quenched free radicals
vastly extends their unique antioxidant powers, helping to maintain an
optimal, synergistic antioxidant balance in the body.
Flavay® is rapidly absorbed and very quickly distributed throughout
the body. As a free radical fighter, Flavay® comes to the aid of
the body more quickly than other antioxidants, reducing the potential
for free radical damage and the ravages of aging. Flavay® also possesses
more reactive sites for neutralizing free radicals than other known antioxidants.
Furthermore, Flavay® permits reactivity with both positively and
negatively charged free radical species. What this means is that Flavay®
can “quench” or “scavenge” (neutralize) a broad variety
of free radicals. Highly reactive as an antioxidant in both lipid (fat)
and aqueous (water) phases, Flavay® neutralizes oxygen free radicals
and is a valuable protector of healthy cells in a variety of internal
conditions. This is a unique property among antioxidants, as most work
either in lipid or aqueous phases, but not both. As a free radical scavenger,
Flavay®
is like an antioxidant prize fighter that can successfully take on all
challengers, big or small, in any kind of weather
All of this means that your immune system works better so
that your joints hurt less and your blood flows better—with Flavay®.
Flavay Plus® Adds Synergistic Help
for Regulating Stress Hormones
Double-blind placebo-controlled research shows that Flavay Plus® can lower stress hormone (cortisol) production
by 30 percent when given to athletes prior
to starting exercise.
Our Customers Say: “I know taking vitamins is good for you but this is much more than that. Because of taking Flavay® and Flavay Plus® I experience substantial improvement in mental sharpness, acuity and in the ability to react quickly and stay on top of situations while auto racing.”
—dentist
Flavay
Plus® is of special interest to athletes as phosphatidyl serine (Leci-PS™),
a complex of amino and fatty acids extracted from soy lecithin, has become popular for building and rebuilding muscle more efficiently. Research shows that phosphatidyl serine slows the release of cortisol following heavy exercise. Cortisol is a hormone that causes muscle tissue to break down. For reasons that are unclear, the body produces increase levels of cortisol after heavy exercise. Strength athletes believe that this natural cortisol release works against their efforts to rapidly build muscle mass so Flavay Plus® may help them advance more quickly.
Flavay Plus also contains a synergistic blend of Flavay® with antioxidant
vitamins, minerals and other phytonutrients to best take advantage of
the dynamic interplay among the antioxidants and their co-factor nutrients. Flavay Plus® is a safe, potentially effective therapeutic agent in keeping
the brain’s processes within normal limits, raising them when they
are low and lowering them when they are high. Both physical and mental
stressful conditions cause stress hormones to be released into circulation,
even in the young and healthy. Phosphatidyl serine given to athletes prior
to starting exercise produced an impressive degree of down-regulation
of the stress hormones. Phosphatidyl serine may have the capacity to normalize
the stress-induced activation of the "fight or flight response."
In a double-blind, placebo-controlled study conducted in Italy, phosphatidyl
serine lowered stress hormone (cortisol) production by 30 percent.
Flavay Plus®'s ability to help concentration means better performance—and fewer mistakes.
Two more recent placebo controlled studies confirmed earlier double-blind
trials; young, university students experienced significantly less stress
from tests when they took phosphatidyl serine (300 mg daily for 30 days),
they stayed more clear-headed and composed, and kept a more stable mood.
Flavay Plus® is an extremely powerful formula for athletes, especially body builders who specifically require faster muscle building and repair. Flavay Plus® provides a healthy edge—completely safe for all drug testing.
REFERENCES:
Masquelier, J. A lifetime devoted to OPC and pycnogenol. Alfa Omega Editrice,
Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice, Publishers,
1995.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing,
Inc., 1997.
Packer, L., et al. The antioxidant miracle: your complete plan. John Wiley
& Sons, Inc., 1999.
Packer, L., et al. Antioxidant food supplements in human health. Academic
Press, 1999.
Lincoln, J., Hoyle, C.H.V., Burnstock, G., Nitric oxide in health and disease.
Cambridge University Press, 1997.
Moncada, S., Nistico, G., Bagetta, G., Higgs, E.A. Nitric oxide and the
cell. Princeton University Press, 1998.
Facino, R.M., et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Passwater, R.A. The antioxidants: the nutrients that guard your body. Keats
Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
Facino RM, et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from Vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes resistant to the
action of mammalian collagenase. Experientia, 37: 221-223, 1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres procyanidoliques.
Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques nouveaux de certains flavonoides.
A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques
totaux du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres flavonoliques.
Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de l’action des
oligomeres procyanidoliques sur des cellules mesenchymateuses en culture.
Ii l’attachment des fibres elastiques aux cellules. (Study of the effect
of procyanidolic oligomers on mesenchymal cells in culture. Ii attachment
of elastic fibers to the cells.) Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular and crystal
structure of (+)-2,3-trans-3,4-trans-leucocyanidin [(2r,3s,+r)-(+)-3,3’,
4.4’, 5.7’-Hexahydroxyflavan] dihydrate, and comparison of its
heterocyclic ring conformation in solution and the solid state. Journal
of the Chemical Society; Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active oxygen free radicals.
Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins b-1 and
b-3 from azuki beans to peroxyl radicals. Agric Biol Chem, 54(10) 1990.
pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different procyanidins
from grape seeds. Presented at a symposium, “Free radicals in biotechnology
and medicine.” Royal Society Of Chemistry, London January 1990, pp.
79-80.
Bauman, J., Wurm, G., Bruchhausen, F. “Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften”
Arch Pharm, (Weinheim) 313 (1980) pp. 330-337.
Lombard, J., et al. The brain wellness plan. Kensington Pub. Corp., 1998.
Flesch M., et al., Effects of red and white wine on endothelium-dependent
vasorelaxation of rat aorta and human coronary arteries. Am J Physiol 1998;275:1183-94.
Fitzpatrick, D.F., Fleming R.C., Bing B, Maggi DA, O'Malley RM. Isolation
and characterization of endothelium-dependent vasorelaxing compounds from
grape seeds. J Agr & Food Chem In press.
Fitzpatrick, D.F., Maggi D, Bing B, Coffey RG. Vasorelaxation, endothelium,
and wine. BioFactors 1997;6:455-459.
Fitzpatrick, D.F., Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent
vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol
1995;26:90-95.
Fitzpatrick, D.F., Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing
activity of wine and other grape products. Amer J Physiol 1993;265:H774-H778.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with catechin
becomes resistant to the action of mammalian collagenase. Experientia, 37:
221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm Arom, 95: 89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro studies that binding
of pycnogenol to elastin affects its rate of degradation by elastases.
Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers extracted
from ‘vitus vinifera l.’ in the rat. European Journal of Drug
Metabolism and Pharmaccokinetics. 1978, No. 1 pp. 15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging activity
of proanthocyanidolic oligomers encapsulated in glycospheres: an in vivo
and in vitro study. Cosmetology Department & S Biovectors, Ramonville
St. Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i converting
enzyme by flavanolic compounds: in vitro and in vivo studies. Planta Medica,
May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez l’animal-oedenme de la patte. Sanofi Res Toul Cedex Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez l’animal-activite aniagoniste vis-a-vis des mediateurs de l’inflamation.
Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance capillaire,
spontanement ou artificiellement diminuee par l’action d’une substance
capillaro-toxique chez des personnes agees--action benefique d’un agnet
actif sur la micro-circulation: l’Endotelon. Inform. Therapeut. 1980.
pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude d’un
microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7, 1990.
Lagrue, G., Olivier-Martin, F., Grillot, A. “Etude des effets des oligomeres
du procyanidol sur las resistance capillaire dand l’hypertension arterielle
et certaines nephropathies.” Sen. Hosp. Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique d’un angioprotecteur peripherique,
l’Endotelon. Actualite Therapeutique Gaz. Med. de France (87)22:2919-24,
1980.
Lesbre, F.X., Tigaud, J.D. Effect de l’Endotelon sur l’indice
de fragilite capillaire dan une population specifique: les sujets cirrhotiques.
Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique des troubles fonctionnels des membres inferieurs
par un microangioprotecteur l’Endotelon. Bordeaux Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de l’Endotelon dans l’insuffisance
veineuse chronique. Therapeutique, la Revue de Medicine, (27-28) Sept. 1981.
pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude de l’Endotelon dand les manifestations
fonctionnelles de l’insuffisance veineuse peripherique-resultats d’une
etude en double aveugle portant sur 92 patients.” Gazette Medicale,
(92)1, 1985. pp. 96-100.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and arachidonate
metabolism in platelets by procyanidins. Prostagland Leukotri Essent Fatty
Acids, 38:181-8, 1989.
Masquelier, J. pycnogenol: recent advances in the therapeutical activity
of procyanidins. Supplement of Planta Medica, Journal of Medicinal Plant
Research and Journal of Natural Products, July 1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury: implications
in atherosclerosis. Free Rad Path & Med, (4)1988 pp. 99-106.
Masquelier, J. “Les procyanidols du vin leur role dans l’alcoolisme.”
pp. 88-93.
Gazave, J.M. “Notions recentes sur les capillaires” unpub. bulletin
from the Laboratoire De Physiologie Patholigie pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation and atherothrombosis.
Office International Vigne et du Vin, Nutrition and Health Unit, Paris France;
Drugs under Experimental and Clinical Research (Switz.) 25/2-3 (125-131),
1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of procyanidin. Acta Physiologica
Academiae Scientiarum Hungaricae, Tomus 56(2):235-240, 1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur l’hyalaluronidase.
Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres procyanidoliques en gynecologie. Essai
Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P “Une Etude Exemplaire Pour Un Phlebotrope: l’etude
EIVE.’ Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres
procyanidoliques dans la paroi des capillaires sanguins du poumon decobaye.
Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. “Collagen treated with (+)
-catechin becomes resistant to the action of mammalian collagenase.”
Laboratory of Connective Tissue Research, Dept. of Biochem. Baylor Col.
of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. “Effect protecteur des oligomeres
procyanidoliques sur le lathyrisme experimental chez le rat.” Ann.
Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal circulation.
Study of the effect of procyanidolic oligomer (Endotelon). Jn. Fr. Opthalmol,
(11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and dazzling:
use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol Fr, 88(2):173-4,
177-9, 1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside oligomers
effects on retinal function in myopic subjects. Ann Ott Clin Ocul, 114:85-93,
1988.
Saracco, J.B., Estachy, G.M. Etude d l’Endotelon en opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr. Opthalmol, 11:453,
1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et O.P.C. Bordeaux Medicale,
(16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy and hemorheology. Bull
Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M. “Les oligomeres procyanidoliques dans le traitement de
la fragilite capillaire et de la retinopathie chez les diabetiques. A propos
de 26 cas.” Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a l’etude des oligomeres procyanidoliques:
Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results of a double-blind
study versus placebo in 32 female patients. Ann Chir Plast Esthet 29(4):393-5,
1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism in
rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62, 1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels. Angiologica,
9:355-374, 1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer, H.J. Berkhauser
Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger., 1977.
Masquelier, J. Action protectrice du vin sur l’ulcere gastrique. Resultats,
p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by flavonoids
and bioflavonoids. Planta Medica, 5116-20, 1985.
Shaw, R. How [Australian] PycnoGenol [MASQUELIER’s®] Helps Sports
People.
Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums Cosmet
Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques
(Endotelon) dans le traitement des lymphoedemes post-therepeutiques de members
superieurs. Symposium Satellite, Congres International d’Angiologie,
Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during 2 weeks
of intense training. Abstract submitted to national meeting of the Amer
College of Sports Medicine, June 1998.
Monteleone, P., Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting by
chronic phosphatidylserine administration of the stress-induced activation
of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm
43: 385–388, 1992.
Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine
administration during two weeks of resistive exercise-induced overtraining.
Bio of Sport 15(3):135-44, 1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres procyanidoliques
sur le cobaye carence en vitamin c. Tavaux Originaux, University of Bordeaux,
1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur l’oxydation
de l’acide ascorbique par les ions cuivriques. Bull. de la Societe
de Chimie Biologique XXXIII (3-4) 1951. pp. 302-304.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur l’acide
ascorbique-oxydase. Bull. de la Societe de Chimie Biologique XXXIII (3,4)
1951. pp.304-306
Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G., Mishioka,
I. “Inhibitory effects of tannins on hyaluronidase activation and on
the degranulation from rat mesentery mast cells.” Chem. Pharm. Bull.
33(11)1985. 5079-5082.
Reiman, H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J. “Histamine
and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress
ulcer formulation by (+)-catechin, an inhibitor of specific histidine decarboxylase
in vitro.” Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. “Les oedemes post-traumatoqies
chez le sportif: essai controle de l’Endothelon.” Actualite Therapeutique
90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al. “Flavonoids et pycnogenol” Int J Vit Nut
Res, (49)3:307-311, 1979.
Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem. Toxicol.
25(2):135-9, 1987.
Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow cells
of the mouse with Pycnogenol. Cytotest Cell Research GmbH & Co., projects
143010 & 143021; Feb. 1989.
Acute and chronic toxicity tests. International Bio-Research, Inc., Hanover,
Germany, 1967-1971.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in vegetable
extracts to be used in the preparation of medicines. Bull. Soc. Pharm. Bordeaux,
129:51-65, 1990.
